SEC Form 4 · accession 0000899243-17-015351
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Denis R Burger
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.57 | Jun 1, 2017 | A | 75,000 | A | — | Jun 1, 2027 | Common Stock | 75,000 | 75,000 | D |
| Stock Options (right to buy)F2 | $0.57 | Jun 1, 2017 | A | 600,000 | A | — | Jun 1, 2027 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F1Subject to stockholder approval, at the next annual meeting, of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, the options will vest in four equal quarterly installments commencing on September 1, 2017.
- F2Subject to stockholder approval, at the next annual meeting, of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, one third of the options will vest on each date that is six months, 18 months and 30 months following the grant date.